menu ☰
menu ˟

Statin, metformin combination reduces prostate cancer mortality, particularly among obese men

01 Jun 2015
CHICAGO – The combined use of statins and metformin reduced disease-specific mortality in patients with prostate cancer, according to population-based study results presented at the ASCO Annual Meeting. Patients with obesity and metabolic syndromes...

Click here to view the full article which appeared in Hematology Oncology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.